These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 17454639)
1. Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation. Merkerova M; Bruchova H; Kracmarova A; Klamova H; Brdicka R Leuk Lymphoma; 2007 Apr; 48(4):793-801. PubMed ID: 17454639 [TBL] [Abstract][Full Text] [Related]
2. [Effect of silencing bmi-1 by RNA interference on function of K562 cell line]. Chen XL; Ren Q; Chen ZP; Zhou ZP; Zhao QJ; Qiu ZY; Dong CL; Han ZC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):266-70. PubMed ID: 19379548 [TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. Gleixner KV; Ferenc V; Peter B; Gruze A; Meyer RA; Hadzijusufovic E; Cerny-Reiterer S; Mayerhofer M; Pickl WF; Sillaber C; Valent P Cancer Res; 2010 Feb; 70(4):1513-23. PubMed ID: 20145140 [TBL] [Abstract][Full Text] [Related]
4. JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation. Merkerova M; Bruchova H; Brdicka R Neoplasma; 2007; 54(6):503-10. PubMed ID: 17949234 [TBL] [Abstract][Full Text] [Related]
5. Expression analysis of PCNA gene in chronic myelogenous leukemia--combined application of siRNA silencing and expression arrays. Merkerova M; Bruchova H; Brdicka R Leuk Res; 2007 May; 31(5):661-72. PubMed ID: 17070905 [TBL] [Abstract][Full Text] [Related]
6. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells. Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109 [TBL] [Abstract][Full Text] [Related]
7. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein. Yong AS; Stephens N; Weber G; Li Y; Savani BN; Eniafe R; Keyvanfar K; Kurlander R; Rezvani K; Barrett AJ Leukemia; 2011 Apr; 25(4):629-37. PubMed ID: 21252986 [TBL] [Abstract][Full Text] [Related]
8. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Bhattacharyya J; Mihara K; Yasunaga S; Tanaka H; Hoshi M; Takihara Y; Kimura A Ann Hematol; 2009 Apr; 88(4):333-40. PubMed ID: 18781299 [TBL] [Abstract][Full Text] [Related]
9. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients. Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759 [TBL] [Abstract][Full Text] [Related]
10. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. Xin T; Zhang FB; Sui GJ; Jin XM Br J Biomed Sci; 2012; 69(2):62-6. PubMed ID: 22872929 [TBL] [Abstract][Full Text] [Related]
11. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway. Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326 [TBL] [Abstract][Full Text] [Related]
12. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells. Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961 [TBL] [Abstract][Full Text] [Related]
13. Bmi-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells. Hosen N; Yamane T; Muijtjens M; Pham K; Clarke MF; Weissman IL Stem Cells; 2007 Jul; 25(7):1635-44. PubMed ID: 17395774 [TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells. Zhang JH; He YL; Zhu R; Du W; Xiao JH Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894 [TBL] [Abstract][Full Text] [Related]